OPKO Health, Inc. Purchase Obligation
OPKO Health, Inc. (OPK) had Purchase Obligation of $40.90 million as of 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:PurchaseObligation · last filed 2026-08-28
- 2026-06-30: Purchase Obligation $40.90M.
- 2026-03-31: Purchase Obligation $36.50M.
- 2025-12-31: Purchase Obligation $33.10M.
- 2025-09-30: Purchase Obligation $10.30M.
| Period end | Purchase Obligation |
|---|---|
| 2026-06-30 | $40.90M 10-Q/A · filed 2026-08-28 |
| 2026-03-31 | $36.50M 10-Q/A · filed 2026-08-28 |
| 2025-12-31 | $33.10M 10-K · filed 2026-02-26 |
| 2025-09-30 | $10.30M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $32.70M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $45.90M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $39.20M 10-K · filed 2025-03-03 |
| 2024-09-30 | $44.00M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $45.80M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $46.50M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $34.70M 10-K · filed 2024-03-01 |
| 2023-09-30 | $44.00M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $46.40M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $52.80M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $58.40M 10-K · filed 2023-02-27 |
| 2022-09-30 | $84.10M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $197.20M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $252.40M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $255.10M 10-K · filed 2022-03-01 |
| 2021-09-30 | $223.70M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $135.50M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $301.50M 10-Q · filed 2021-04-28 |
| 2020-12-31 | $342.20M 10-K · filed 2021-02-18 |
| 2020-09-30 | $196.10M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $154.20M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $101.10M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $89.20M 10-K · filed 2020-03-02 |
| 2019-09-30 | $77.50M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $69.80M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $93.50M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $98.50M 10-K · filed 2019-03-01 |
| 2018-09-30 | $85.70M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $84.40M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $82.50M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $82.20M 8-K · filed 2019-01-29 |
| 2017-09-30 | $106.60M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $107.50M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $82.70M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $90.30M 10-K · filed 2017-03-01 |
| 2016-09-30 | $71.90M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $54.40M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $27.10M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $48.30M 10-K · filed 2016-02-29 |
| 2015-09-30 | $19.30M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $19.20M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $13.90M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $14.70M 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |